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a b s t r a c t
A good contrast echocardiographic study enhances the safety and efﬁcacy of alcohol
ablation procedures. Newer generation echocardiographic contrast agents and conventional
radiographic contrast agents when used as echocardiographic contrast agents for this
purpose are often unsatisfactory. We describe the use of agitated modiﬁed gelatin, a cheap
and readily available agent that provides excellent echocardiographic images and identiﬁes
the myocardium supplied by the targeted septal artery.
# 2015 Cardiological Society of India. Published by Elsevier B.V. This is an open access
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and efﬁcacy of alcohol ablation procedures. The echocardio-
graphic contrast agentwhen injected into the target artery can
reliably identify the myocardium supplied by the artery. First
generation echo contrast agents like levovist® were good
agents in this regard. These are however no longer available.
Newer generation echocardiographic contrast agents or
conventional radiographic contrast agents used as echocar-
diographic contrast agents are very often unsatisfactory. We
describe the use of agitated modiﬁed gelatin, a cheap and
readily available agent that provides excellent echocardio-
graphic images.
A 60-year-old male complained of mild exertional breath-
lessness since the age of 15–20 years. His symptoms had
increased for the past 10 years and presently he had
breathlessness, chest heaviness, palpitations, and fatigue on* Corresponding author.
E-mail address: drajaybahl@hotmail.com (A. Bahl).
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).walking 100 m on level ground. His ECG showed left ventricu-
lar hypertrophywith strain pattern. Echocardiography showed
asymmetrical septal hypertrophy with maximal left ventricu-
lar wall thickness of 25 mm, complete systolic anteriormotion
ofmitral valve withmoderatemitral regurgitation, and resting
left ventricular outﬂow tract gradient of 113 mm. He ﬁrst
presented to us 4 years back and was started on metoprolol
and disopyramide. He hadmarked symptomatic improvement
and increased his walking distance to over 2 km. On stopping
disopyramide, he once again developed severe symptoms and
was now taken up for alcohol septal ablation.
Coronary angiography showed a plaque in the left anterior
descending artery and its diagonal branch. ATW guidewire®
(Cordis) was passed into the ﬁrst large septal branch of the left
anterior coronary artery. A 1.5 mm  10 mm Sprinter® over-
the-wire semicompliant balloon (Medtronic) was passed overB.V. This is an open access article under the CC BY-NC-ND license
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Fig. 1 – (A) Coronary guidewire and central marker of over the wire balloon (arrow) seen in the first septal branch that was
ablated. (B) Apical four chamber view showing the interventricular septum prior to injection of agitated gelatin. (C and D)
Apical four chamber view following injection of agitated gelatin through the central lumen of the coronary balloon. Bright
gelatin depot in the basal interventricular septum is clearly seen (arrows). The depot extends across the septal-mitral contact
point.
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just distal to the septal osteum (Fig. 1A). The balloon was
inﬂated to 7 atmpressure. Radiographic contrast injection into
the left coronary artery showed no leakage of contrast into the
septal branch across the balloon.
Agitated gelofusine® (B Braun Medical, India) was used as
an echocardiographic contrast agent. Gelofusine contains 4%
modiﬁed liquid gelatin. Two 5 ml luer lock syringes were
connected across a 3-way stopcock. 5 ml gelofusine was taken
in one syringe and 1 ml gelofusine along with 2 ml air in the
other syringe. The gelofusine–air mixture was vigorously
agitated between the syringes across the 3-way stopcock. The
gelofusine–air mixture formed a milky ﬂuid with no visible air
bubbles. 2–3 ml of this ﬂuid was now injected into the central
lumen of the over-the-wire balloon. On echocardiography, an
excellent contrast depotwas seen in basal septumwell beyond
septal mitral contact point (Fig. 1C and D) as compared to the
baseline (Fig. 1B). Thus, themyocardium supplied by the target
septal artery was well delineated. 2.2 ml absolute alcohol was
now slowly injected into the central lumen of the over-the-
wire balloon. Post-procedure, the target septal branch had noresidual ﬂow. Resting gradient across the left ventricular
outﬂow tract dropped from 92 to 30 mmHg.
It is important to identify the extent of myocardium being
supplied by the target septal artery since alcohol will cause
myocardial necrosis in the septal territory. By far, the most
reliable investigation is contrast echocardiography with the
contrast agent being injected into the septal through the
central lumen of the balloon. A reliable contrast echocardiog-
raphywill not only conﬁrm that the targetmyocardium (across
the septal-mitral contact point in a typical left ventricular
outﬂow tract obstruction) is being adequately supplied by the
septal but will also identify areas of myocardium areas of
anomalous supply like right ventricular free wall and papillary
muscles. Conﬁrmation of the myocardium supplied by the
targeted artery increases the safety and efﬁcacy of all alcohol
ablation procedures. The importance of identifying the
affected myocardium is even more when atypical regions like
left ventricular mid-cavity or right ventricular muscle bands
are targeted for ablation.
Various echocardiographic contrast agents have been tried.
The usual radiographic contrast agents are often used instead
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the myocardium perfused by the septal branch. Echocardio-
graphic visualization with radiographic contrast agents is
sub-optimal and the contrast depot in themyocardium is not
very echogenic. This is exempliﬁed by the fact that the
echogenicity of these agents is far less than the alcohol that is
subsequently injected. Areas of anomalous supply like the
papillary muscle and right ventricular free wall that have a
lower contrast density may not get highlighted with radio-
graphic contrast agents. However, radiographic contrast
agents are often well visualized in areas with high contrast
density like the septum.
Various echocardiographic contrast agents have also been
tried for this procedure. First, generation echocardiographic
contrast agents like levovist® (Schering, Berlin, Germany) were
good contrast agents for this purpose.1 First generation
echocardiographic contrast agents, however, are no longer
available in many countries. Newer generation echo contrast
agents are now widely available. These unfortunately are not
very suitable for the procedure. Unlike the ﬁrst generation
agents, the second generation echo contrast agents pass more
efﬁciently through the capillary bed and are thus preferred
agents for intravenous contrast echocardiography.3 This very
property that makes them good agents for use as intravenous
contrast, make them less suitable as contrast echo agents in
myocardial contrast echocardiography. Since they rapidly
pass through the capillary bed, they do not form a good depot
in themyocardium, instead they rapidly get washed out of the
myocardium into the ventricular cavity.2
Modiﬁed gelatin is widely available as a volume expander
and cold agitated has beenused an echocardiographic contrast
agent.4 As seen in Fig. 1C and 1D, agitated modiﬁed gelatin
(gelofusine®) forms an excellent depot in themyocardium and
hence provides excellent echocardiographic contrast. Thisdepot was as echogenic as that subsequently formed by
alcohol. We had used agitated gelofusine® stored at room
temperature. It is cheap, beautifully lights up themyocardium,
and is probably the best echocardiographic contrast agent for
alcohol ablation procedures available today.
To conclude, agitated gelatin forms a very echogenic depot
in the myocardium. Hence, agitated gelatin is excellent and
probably the best echocardiographic contrast agent available
today for identifyingmyocardium supplied by the septal artery
prior to alcohol septal ablation.
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